isoniazid and bm 212
isoniazid has been researched along with bm 212 in 7 studies
Research
Studies (7)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (14.29) | 18.2507 |
| 2000's | 3 (42.86) | 29.6817 |
| 2010's | 3 (42.86) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
Authors
| Authors | Studies |
|---|---|
| Biava, M; Deidda, D; Fioravanti, R; Maullu, C; Pompei, R; Porretta, GC | 1 |
| Biava, M; Botta, M; Deidda, D; Manetti, F; Molicotti, P; Poce, G; Pompei, R; Porretta, GC; Supino, S | 1 |
| Biava, M; Botta, M; De Logu, A; De Rossi, E; Manetti, F; Meleddu, R; Poce, G; Porretta, GC; Saddi, M | 1 |
| Bhakta, S; Brown, AK; Castagnolo, D; Dasugari, S; Evangelopoulos, D; Maitra, A; Manetti, F; McHugh, TD; Mortazavi, PN; Petricci, E; Scalacci, N; Twist, A | 1 |
| Chakraborti, AK; Dhameliya, TM; Jadhavar, PS; Pancholia, S; Shah, P; Sridevi, JP; Sriram, D; Yogeshwari, P | 1 |
| Anand, A; B, S; Gokhale, R; Kumar, V; Ramesh, R; Shingare, RD; Srinivasa Reddy, D; Ummanni, R; Veeraraghavan, S; Viswanadha, S | 1 |
| Biava, M; Cesare Porretta, G; Deidda, D; Manetti, F; Pompei, R; Tafi, A | 1 |
Other Studies
7 other study(ies) available for isoniazid and bm 212
| Article | Year |
|---|---|
New pyrrole derivatives as antimycobacterial agents analogs of BM212.
Topics: Antitubercular Agents; Microbial Sensitivity Tests; Mycobacterium; Piperazines; Pyrroles | 1999 |
Antimycobacterial agents. Novel diarylpyrrole derivatives of BM212 endowed with high activity toward Mycobacterium tuberculosis and low cytotoxicity.
Topics: Animals; Antitubercular Agents; Chlorocebus aethiops; Microbial Sensitivity Tests; Models, Molecular; Morpholines; Mycobacterium tuberculosis; Piperazines; Pyrroles; Quantitative Structure-Activity Relationship; Vero Cells | 2006 |
1,5-Diphenylpyrrole derivatives as antimycobacterial agents. Probing the influence on antimycobacterial activity of lipophilic substituents at the phenyl rings.
Topics: Antitubercular Agents; Drug Resistance, Multiple, Bacterial; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Nontuberculous Mycobacteria; Piperazines; Pyrroles; Structure-Activity Relationship | 2008 |
Design and Synthesis of 1-((1,5-Bis(4-chlorophenyl)-2-methyl-1H-pyrrol-3-yl)methyl)-4-methylpiperazine (BM212) and N-Adamantan-2-yl-N'-((E)-3,7-dimethylocta-2,6-dienyl)ethane-1,2-diamine (SQ109) Pyrrole Hybrid Derivatives: Discovery of Potent Antitubercul
Topics: Adamantane; Antitubercular Agents; Carrier Proteins; Cell Line; Cell Survival; Computational Biology; Drug Design; Drug Resistance, Multiple, Bacterial; Ethylenediamines; Humans; Microbial Sensitivity Tests; Models, Molecular; Mycobacterium; Mycobacterium tuberculosis; Pharmaceutical Preparations; Piperazines; Pyrroles; Structure-Activity Relationship | 2016 |
Benzo[d]thiazol-2-yl(piperazin-1-yl)methanones as new anti-mycobacterial chemotypes: Design, synthesis, biological evaluation and 3D-QSAR studies.
Topics: Animals; Antitubercular Agents; Chemistry Techniques, Synthetic; Drug Design; Mice; Microbial Sensitivity Tests; Models, Molecular; Molecular Conformation; Mycobacterium tuberculosis; Piperazine; Piperazines; Quantitative Structure-Activity Relationship; RAW 264.7 Cells | 2016 |
Repurposing of a drug scaffold: Identification of novel sila analogues of rimonabant as potent antitubercular agents.
Topics: Antitubercular Agents; Drug Repositioning; Hep G2 Cells; Humans; Microbial Sensitivity Tests; Models, Molecular; Molecular Conformation; Mycobacterium tuberculosis; Piperidines; Pyrazoles; Rimonabant; Structure-Activity Relationship | 2016 |
Importance of the thiomorpholine introduction in new pyrrole derivatives as antimycobacterial agents analogues of BM 212.
Topics: Anti-Bacterial Agents; Antibiotics, Antitubercular; Antifungal Agents; Antitubercular Agents; Antiviral Agents; Binding Sites; Chemical Phenomena; Chemistry, Physical; Indicators and Reagents; Isoniazid; Microbial Sensitivity Tests; Models, Molecular; Molecular Conformation; Morpholines; Mycobacterium; Piperazines; Pyrroles; Rifampin; Streptomycin; Structure-Activity Relationship | 2003 |